This report evaluates the clinical validity and clinical utility of the Cxbladder Detect test (Pacific Edge Ltd.).
Molecular Test Assessments
Molecular Test Assessments are comprehensive health technology assessments of molecular tests across a range of conditions and applications. Each report provides a clear, objective view of the science behind a specific molecular test, the clinical evidence supporting the test, the manufacturer, an explanation of how the test is used in clinical practice, and appropriate patient selection criteria.
These reports include the Hayes Rating to indicate the overall strength and direction of the body of evidence for the molecular test. Molecular Test Assessments provide evidence-based support for the development of coverage policy, utilization management, and evidence-based clinical practices. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.
FoundationOne Heme (Foundation Medicine Inc.)
This report evaluates the clinical validity and clinical utility of the FoundationOne Heme test.
NavDx (Naveris)
This report evaluates the clinical validity and clinical utility of the NavDx test.
Vectra (Laboratory Corporation of America Holdings)
This report evaluates the clinical validity and clinical utility of the Vectra test (Laboratory Corporation of America Holdings).
Cxbladder Monitor (Pacific Edge Ltd.)
This report evaluates the clinical validity and clinical utility of the Cxbladder Monitor test.
Multitarget Panels for Identification of Vaginal Pathogens
Percepta Genomic Sequencing Classifier (Veracyte Inc.)
This report evaluates the clinical validity and clinical utility of the Percepta Genomic Sequencing Classifier (GSC) test (Veracyte Inc.).
Guardant360 CDx (Guardant Health Inc.)
This report evaluates the impact of the Guardant360 CDx test (Guardant Health Inc.) as a companion diagnostic on patient survival.
GeneStrat (Biodesix Inc.)
This report evaluates the clinical validity and clinical utility of the GeneStrat targeted genomic test (Biodesix Inc.).
Cologuard (Exact Sciences Corp.) for Colorectal Cancer Screening in Average-Risk Adults
This report evaluates the clinical validity and clinical utility of the Cologuard test (Exact Sciences Corp.).